According to INmune Bio's latest financial reports the company's current EPS (TTM) is -1,65 โฌ. In 2022 the company made an earnings per share (EPS) of -1,39 โฌ an increase over its 2021 EPS that were of -1,71 โฌ.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -1,68 โฌ | |
2022 | -1,39 โฌ | -19.15% |
2021 | -1,71 โฌ | 86.14% |
2020 | -0,92 โฌ | 34.67% |
2019 | -0,68 โฌ | -32.36% |
2018 | -1,01 โฌ | 1396.12% |
2017 | -0,06760 โฌ | 199.64% |
2016 | -0,02256 โฌ |